What is the main business of Bitres?

The main business activity of Bitres focuses on research and experimental development on biotechnology.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on September 13, 2019.

Where is the headquarters located?

The headquarters is located at: ul. Tytusa Chałubińskiego 9, 02-004 Warszawa.

What is the share capital?

The share capital of the company is PLN 10,000 (approx. $2,701).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What was the revenue?

The company reported a revenue of $1 in 2025, which is a decrease of 100.0% compared to 2024.

No, in 2025 the company reported a net loss of $4,740.

What is the main operating cost?

The largest operating cost category falls under other operating costs. This category amounted to $3,183 in 2025, representing 67% of all operating expenses.

Bitressp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2019-09-13

Share capital

10,000.00 PLN

Activity description

Bitres develops AI-based voice biometrics systems for speaker verification and identification in Zoom, Teams, VoIP, conference calls, and call centers. It also provides real-time speech-to-text transcription with Polish language support. Services can be deployed in the cloud or on the customer’s infrastructure, including under the customer’s brand.

Registered address

ul. Tytusa Chałubińskiego 9/2, 02-004 Warszawa, Poland

Website

bitres.pl

Phone

Electronic delivery address

AE:PL-61913-55776-WDHRG-21

Financials

Revenue history (in k)

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 75 days late).

202513/04/2026
202430/04/2025
202327/05/2024
202213/06/2023
202128/09/2022
202029/09/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 0.59MedianUSD 55.24kAverageUSD 2.71m

Net profit

This companyUSD -4.74kMedianUSD -1.27kAverageUSD -91.85k

Operating costs

This companyUSD 4.73kMedianUSD 65.85kAverageUSD 2.66m

Assets

This companyUSD 19.10kMedianUSD 133.19kAverageUSD 3.03m

Industry

Offer

Voice biometric verification
Speaker identification
Speech transcription
Speech recognition software
Voice system deployment

Authorized Representatives

Kamil Adam Kamiński – Attorney-in-fact

Martyna Lejkowska – President of the Management Board

Wojciech Lejkowski – Attorney-in-fact

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Kamil Adam Kamińskiage 38	100	$1,350.62	50%
Wojciech Lejkowskiage 36	100	$1,350.62	50%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2019-09-25.

ING Bank Śląski
28 1050 1025 1000 0090 8070 8614
ING Bank Śląski
81 1050 1025 1000 0090 8070 8630
ING Bank Śląski
06 1050 1025 1000 0090 8070 8622

Debt

No entries in the National Debtors Register (KRZ).

Public aid

Grant date	Purpose	Gross amount	Granting body
Jun 26, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$1,282$1,282	Prezydent Miasta Stołecznego Warszawy
May 21, 2020	Aid for SME access to finance — aid for start-ups	$33,323$33,323	Fundacja Przedsiębiorczości Technologicznej
Nov 4, 2019	De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)	$13,538$13,538	Fundacja Mobile Open Society Through Technology (Most)

Competitors

	Name	Revenue	Website
	ImmunotronicsP.S.A.	$0.16	immunotronics.net

FAQ

Last updated: 2026-04-14